# Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events

> **NCT01173029** · — · COMPLETED · sponsor: **Universidade Gama Filho** · enrollment: 92 (actual)

## Conditions studied

- Systemic Arterial Hypertension
- Hypertension Resistant to Conventional Therapy
- Myocardial Infarction
- Stroke

## Interventions

- **DRUG:** Anti-hypertensive drug treatment

## Key facts

- **NCT ID:** NCT01173029
- **Lead sponsor:** Universidade Gama Filho
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2009-11
- **Final completion:** 2010-12
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2013-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173029, "Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01173029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*